Biological API Drug Manufacturing Market Outlook, Competitive Analysis and Forecast 2024-2031
Published: 2024 February 02
SKU : MD787
180 pages
Report Summary
Table of Contents
Buy this report
Single User
$4350
Multiple User
$4850
Enterprise User
$7850
Request new version
FAQ’s
What is the Projected CAGR value of the Biological API Drug Manufacturing Market?
Biological API Drug Manufacturing Market is expected to grow at a CAGR of 6.2% during the forecast period 2024-2031.
Who are the key players in Biological API Drug Manufacturing Market?
Major players are Lonza, Boehringer Ingelheim BioXcellence, Celltrion, DSM Biologics, Samsung BioLogics, Fujifilm Diosynth Biotechnologies and Cytovance Biologics.
Related Reports
medical-devicesPneumatic Tourniquets Market Size, Share, Industry, Forecast and outlook (2023-2030)
Published: 2023 February 10
Starting from
$4350
medical-devicesCellulite Treatment Market Size, Share, Industry, Forecast and outlook (2023-2030)
Published: 2023 March 20
Starting from
$4350
medical-devicesBilirubin Meters Market Size, Share, Industry, Forecast and outlook (2023-2030)
Published: 2022 June 06
Starting from
$4350
medical-devicesPercutaneous Drainage Catheters Market Size, Share, Industry, Forecast and outlook (2023-2030)
Published: 2023 December 28
Starting from
$4350
medical-devicesChest Drainage Catheter Market Size, Share, Industry, Forecast and outlook (2024-2031)
Published: 2024 February 13
Starting from
$4350
medical-devicesExtracellular Matrix Patches Market Size, Share, Industry, Forecast and outlook (2023-2030)
Published: 2023 September 26
Starting from
$4350